menu ☰
menu ˟

Sienna Biopharmaceuticals acquires drug candidates for treating psoriasis, atopic dermatitis

07 Dec 2016
Sienna Biopharmaceuticals announced it has acquired Creabilis plc, a specialty pharmaceutical company focused on developing topical treatments for inflammatory skin conditions, including psoriasis, atopic dermatitis and pruritus.Among the first-in-cl...

Click here to view the full article which appeared in Allergy Immunology

IPH Logo